Skip to main content

Grey Cloak Tech Inc. Introduces New, BergaMet NA IMMUNE Product

Written by Customer Service on . Posted in Public Companies.

LAS VEGAS, April 29, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Grey Cloak Tech Inc. (OTC: GRCK) (the “Company”), engaged in proprietary development of natural plant-based formulations, sales and distribution of cardiovascular and neuro products, announces the launch of its new Citrus Bergamot SuperFruit™ IMMUNE product developed by the Company’s BergaMet NA subsidiary. BergaMet NA’s proprietary formulation naturally promotes healthy immune systems in humans, and is especially designed to support cardiovascular health, blood sugar maintenance, address internal inflammation, and other metabolic conditions.  
Kevin “Duke” Pitts, CEO of Grey Cloak Tech, states, “I am excited to add Citrus Bergamot SuperFruit™ IMMUNE to our great lineup of products. The expansion of our product offerings underscores our commitment to provide people an all-natural solution formulated to improve metabolic syndrome. As everyone knows a healthy diet and exercise are important for overall well-being, however, not everyone can achieve their desired results.  Consumers can start taking control of their own health with two daily Citrus Bergamot SuperFruit™ tablets for less than a dollar a day.”BergaMet NA distributes and sells the highest concentration of Citrus Bergamot SuperFruit™ products, which addresses heart health, blood sugar maintenance, inflammation, and other metabolic conditions, as verified with 17 published experimental studies and human trials.BergaMet’s IMMUNE, HERHEART, SPORTSHEART and other products can be found at www.BergaMetNA.com as well as on Amazon, other online retailers and in doctors’ offices throughout the United States.About Grey Cloak Tech Inc. 
Grey Cloak Tech Inc. (OTC: GLCK), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients, is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of cardiovascular and neuro products. For more information, visit the company’s websites: http://greycloaktech.com, http://bergametna.com , http://ubnutrients.comForward-Looking Statements and Safe Harbor Notice
 All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility,” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2018, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release. 
Grey Cloak Tech Inc.:
 Info@GreyCloakTech.com
www.GreyCloakTech.com 
Corporate Communications:
 InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.